CDK4 and neoplasm: The first-generation CDK inhibitors are “pan-CDK” inhibitors, including flavopiridol and seliciclib (roscovitine).10,11 In recent years, targeted therapies against CDKs have made considerable progress in the field of tumor therapy, of which CDK4/6 specific inhibitors have been the first to be established as effective.